| Product NDC: | 55154-1125 |
| Proprietary Name: | FORTAZ |
| Non Proprietary Name: | ceftazidime |
| Active Ingredient(s): | 20 mg/mL & nbsp; ceftazidime |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55154-1125 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050578 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19920826 |
| Package NDC: | 55154-1125-5 |
| Package Description: | 5 VIAL in 1 BAG (55154-1125-5) > 50 mL in 1 VIAL |
| NDC Code | 55154-1125-5 |
| Proprietary Name | FORTAZ |
| Package Description | 5 VIAL in 1 BAG (55154-1125-5) > 50 mL in 1 VIAL |
| Product NDC | 55154-1125 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ceftazidime |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 19920826 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | CEFTAZIDIME SODIUM |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |